These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. The mesolimbic dopaminergic pathway is more resistant than the nigrostriatal dopaminergic pathway to MPTP and MPP+ toxicity: role of BDNF gene expression. Hung HC; Lee EH Brain Res Mol Brain Res; 1996 Sep; 41(1-2):14-26. PubMed ID: 8883930 [TBL] [Abstract][Full Text] [Related]
25. Glutamic acid decarboxylase gene expression in the dopamine-denervated striatum: effects of intrastriatal fetal nigral transplants or chronic apomorphine treatment. Cenci MA; Campbell K; Björklund A Brain Res Mol Brain Res; 1997 Aug; 48(1):149-55. PubMed ID: 9379836 [TBL] [Abstract][Full Text] [Related]
26. Effects of graft-derived dopaminergic innervation on the target neurons of patch and matrix compartments of the striatum. Rajakumar N; Rushlow W; Rajakumar B; Naus CC; Stoessl AJ; Flumerfelt BA Neuroscience; 1997 Feb; 76(4):1173-85. PubMed ID: 9027877 [TBL] [Abstract][Full Text] [Related]
27. Similar time course changes in striatal levels of glutamic acid decarboxylase and proenkephalin mRNA following dopaminergic deafferentation in the rat. Vernier P; Julien JF; Rataboul P; Fourrier O; Feuerstein C; Mallet J J Neurochem; 1988 Nov; 51(5):1375-80. PubMed ID: 2459307 [TBL] [Abstract][Full Text] [Related]
28. Mechanisms of amphetamine-induced rotation in rats with unilateral intrastriatal grafts of embryonic dopaminergic neurons: a pharmacological and biochemical analysis. Herman JP; Rouge-Pont F; Le Moal M; Abrous DN Neuroscience; 1993 Apr; 53(4):1083-95. PubMed ID: 8099430 [TBL] [Abstract][Full Text] [Related]
29. Downregulation of muscarinic receptors in the rat caudate-putamen after lesioning of the ipsilateral nigrostriatal dopamine pathway with 6-hydroxydopamine (6-OHDA): normalization by fetal mesencephalic transplants. Dawson TM; Dawson VL; Gage FH; Fisher LJ; Hunt MA; Wamsley JK Brain Res; 1991 Feb; 540(1-2):145-52. PubMed ID: 1905173 [TBL] [Abstract][Full Text] [Related]
30. Influence of nigrostriatal dopaminergic tone on the biosynthesis of dynorphin and enkephalin in rat striatum. Li SJ; Jiang HK; Stachowiak MS; Hudson PM; Owyang V; Nanry K; Tilson HA; Hong JS Brain Res Mol Brain Res; 1990 Aug; 8(3):219-25. PubMed ID: 1977070 [TBL] [Abstract][Full Text] [Related]
31. Differential regulation of striatal preproenkephalin mRNA by D1 and D2 dopamine receptors. Pollack AE; Wooten GF Brain Res Mol Brain Res; 1992 Jan; 12(1-3):111-9. PubMed ID: 1312196 [TBL] [Abstract][Full Text] [Related]
32. Rats with unilateral median forebrain bundle, but not striatal or nigral, lesions by the neurotoxins MPP+ or rotenone display differential sensitivity to amphetamine and apomorphine. Sindhu KM; Banerjee R; Senthilkumar KS; Saravanan KS; Raju BC; Rao JM; Mohanakumar KP Pharmacol Biochem Behav; 2006 Jun; 84(2):321-9. PubMed ID: 16820197 [TBL] [Abstract][Full Text] [Related]
33. Functional recovery of supersensitive dopamine receptors after intrastriatal grafts of fetal substantia nigra. Dawson TM; Dawson VL; Gage FH; Fisher LJ; Hunt MA; Wamsley JK Exp Neurol; 1991 Mar; 111(3):282-92. PubMed ID: 1825638 [TBL] [Abstract][Full Text] [Related]
34. Release of dopamine by perfusion with 1-methyl-4-phenylpyridinium ion (MPP(+)) into the striatum is associated with hydroxyl free radical generation. Obata T; Yamanaka Y; Kinemuchi H; Oreland L Brain Res; 2001 Jul; 906(1-2):170-5. PubMed ID: 11430875 [TBL] [Abstract][Full Text] [Related]
35. Nerve growth factor (NGF) potentiates the changes in striatal proenkephalin mRNAs subsequent to 6-hydroxydopamine-induced lesions of the substantia nigra. Cadet JL; Angulo JA; McEwen BS Brain Res Bull; 1990 Sep; 25(3):401-5. PubMed ID: 2127237 [TBL] [Abstract][Full Text] [Related]
36. Dopaminergic regulation of striatal proenkephalin mRNA and prodynorphin mRNA: contrasting effects of D1 and D2 antagonists. Morris BJ; Höllt V; Herz A Neuroscience; 1988 May; 25(2):525-32. PubMed ID: 3041310 [TBL] [Abstract][Full Text] [Related]
37. Implantation of genetically modified mesencephalic fetal cells into the rat striatum. Zhu SM; Kujirai K; Dollison A; Angulo J; Fahn S; Cadet JL Brain Res Bull; 1992 Jul; 29(1):81-93. PubMed ID: 1504854 [TBL] [Abstract][Full Text] [Related]
38. Intrastriatal dopamine-rich implants reverse the changes in dopamine D2 receptor densities caused by 6-hydroxydopamine lesion of the nigrostriatal pathway in rats: an autoradiographic study. Savasta M; Mennicken F; Chritin M; Abrous DN; Feuerstein C; Le Moal M; Herman JP Neuroscience; 1992; 46(3):729-38. PubMed ID: 1532053 [TBL] [Abstract][Full Text] [Related]
39. Autoregulation of dopamine release and metabolism by intrastriatal nigral grafts as revealed by intracerebral dialysis. Strecker RE; Sharp T; Brundin P; Zetterström T; Ungerstedt U; Björklund A Neuroscience; 1987 Jul; 22(1):169-78. PubMed ID: 2819773 [TBL] [Abstract][Full Text] [Related]
40. Acute effects of intranigral application of MPP+ on nigral and bilateral striatal release of dopamine simultaneously recorded by microdialysis. Santiago M; Rollema H; de Vries JB; Westerink BH Brain Res; 1991 Jan; 538(2):226-30. PubMed ID: 1707325 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]